Szabo, R.; Petrișor, C.; Bodolea, C.; Dobre, V.; Tranca, S.; Clichici, S.; Szabo, I.; Melinte, R.M.; Mocan, T.
Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19. Pharmaceutics 2023, 15, 646.
https://doi.org/10.3390/pharmaceutics15020646
AMA Style
Szabo R, Petrișor C, Bodolea C, Dobre V, Tranca S, Clichici S, Szabo I, Melinte RM, Mocan T.
Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19. Pharmaceutics. 2023; 15(2):646.
https://doi.org/10.3390/pharmaceutics15020646
Chicago/Turabian Style
Szabo, Robert, Cristina Petrișor, Constantin Bodolea, Vlad Dobre, Sebastian Tranca, Simona Clichici, Iulia Szabo, Razvan Marian Melinte, and Teodora Mocan.
2023. "Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19" Pharmaceutics 15, no. 2: 646.
https://doi.org/10.3390/pharmaceutics15020646
APA Style
Szabo, R., Petrișor, C., Bodolea, C., Dobre, V., Tranca, S., Clichici, S., Szabo, I., Melinte, R. M., & Mocan, T.
(2023). Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19. Pharmaceutics, 15(2), 646.
https://doi.org/10.3390/pharmaceutics15020646